31 Mar 2017 | 5:18 AM
 

Samrat Pharmachem Ltd. Share Price Live (BSE)
0

BSE Code: 530125 | NSE Symbol:
75.25
3.55
(4.96 %)
30 Mar 2017 | 03:45 PM
Change company
  • Open (Rs)
    75.25
  • Prev. close (Rs.)
    71.70
  • High (Rs.)
    75.25
  • Low (Rs.)
    75.20
  • 52W H (Rs.)
    81.50
  • 52W L (Rs.)
    25.00
  • Volume (Rs.)
    11056
  • MCap (Rs in Cr.)
    23.26
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

News

30 Mar 2017 - 16:16:00-Pharma major Aurobindo Pharma Ltd on Thursday said it has received final nod from the US health regu...
30 Mar 2017 - 12:15:00-Shares of Aurobindo Pharma advanced over 1 per cent on the Bombay Stock Exchange after the drug make...
30 Mar 2017 - 09:32:00-Leading pharma major Glenmark Pharmaceuticals has said that it has got positive results for GSP 301 ...
29 Mar 2017 - 11:52:00-Shares of Dishman Pharmaceuticals rallied over 15 per cent on the Bombay Stock Exchange after the dr...

Announcements

14-Feb-2017
Samrat Pharma - Standalone Financial Results Limited Review Report for December 31 2016
12-Jan-2017
Samrat Pharma - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended December
11-Jan-2017
Samrat Pharma - Board Meeting Intimation for Results & Closure of Trading Window
11-Jan-2017
Samrat Pharma - Shareholding for the Period Ended December 31 2016
14-Nov-2016
Samrat Pharma - Standalone Financial Results Limited Review Report for September 30 2016

Religare Research

30 Mar 2017 | 09:42 AM
• Gold extended retreat from a one month high • Oil prices spiked on lower than expected inventory b...
30 Mar 2017 | 09:33 AM
The Indian rupee rose to a more than 17 month high against the dollar, helped by bunched up inflows ...
30 Mar 2017 | 09:01 AM
Huhtamaki PPL Ltd (HPPL) is India's leading manufacturer of primary consumer packaging and labelling...
30 Mar 2017 | 07:00 AM
Keeping in mind volatile market condition, we reiterate our view to limit leveraged positions and wa...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors47.83%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII3.24%
Government0.00%
Others7.87%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,475.55(1.35)
3578
 Kovai Medical Center and Hospital Ltd.
1,300.50(-0.73)
11816
 Merck Ltd.
1,034.65(0.26)
3302
 AstraZeneca Pharma India Ltd.
936.05(0.56)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Samrat Pharmachem Ltd.5.9534.1033.90
NIFTY(S&P CNX)294.15987.95562.60
BSE SENSEX904.103,020.961,781.46
BSE 500428.351,568.86904.65

Corporate Details

Key Personal
Lalit Mehta
Chairman & M.D & CEO
Megh Mehta
Executive Director
Rajesh Mehta
Executive Director & CFO
Key Address
Registered Office
Plot No A2/3445 GIDC Phase IV,Ankleshwar,Gujarat

Tel:02646-220774 251291 22077, Fax:02646-251291

samrat@bom4.vsnl.net.in
http://www.samratpharmachem.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Samrat Pharmachem Ltd. that will help you decide whether to buy, sell or hold Samrat Pharmachem Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Samrat Pharmachem Ltd.